Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
US9068228B2 · kind B2 · utility
0Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2014 |
| Grant date | Jun 30, 2015 |
| Priority date | — |
| Expiry date | Nov 6, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/202
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a method for screening and evaluating ameliorants of dry skin caused by atopic dermatitis, comprising: evaluating a candidate drug as being an ameliorant of dry skin caused by atopic dermatitis in the case the candidate drug significantly increases expression and/or activity of bleomycin hydrolase in comparison with a control drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.